Abstract
End-of-August updates for Covid-19 infection case predictions for 10 US States (NY, WA, GA, IL, MN, FL, OH, MI, CA, and NC) are compared to actual data. Several states that experienced significant summer surges gained control of accelerating infection spread during August. The US as a whole and the 10 States investigated continue to follow periods of linear infection growth that defines a boundary separating accelerated infection growth and infection decay.
August 31 predictions (initiated July 27, 2020) for four States (NY, WA, MI and MN) are within 10% of actual data. Predictions for four other States (GA, IL, CA, and OH) agree between 10 and 20% of actual data. Predictions for two States (FL and NC) are greater than 20% different from actual data. Systematic differences between predictions and actual data are related to the impact of the June-July summer surge, and human behavior reactions (ie, increased face mask usage and distancing) to accelerated infection growth.
Outdoor temperature effects and school re-opening effects are not apparent nor expected for August. Human behavior parameters (Social Distance Index, SDI, and disease transmission efficiency, G, parameters) are adjusted to mirror August data. Comparisons of actual versus predicted daily new infection cases display the complexity of SARS-CoV-2 transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No research support has been received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB oversight is required for this work.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data sources are cited and are publicly available.
